GenSurgTools.jpg

Please note the above button will take you to Mailchimp

Learn more our privacy practices here


THe 13th LONDON SURGICAL SYMPOSIUM

LSS 2017.png.jpg

#LSS2019

16/10/19

The 72nd Simpson-Smith Lecture and Awards

 


Please note the above button will take you to Eventbrite

Please note the above button will take you to the Imperial Online Shop


In Association with:

 
 
 
 
 

With special thanks to:

Logo_for_Imperial_College_London.svg.png

 

logo-nihr4[16899].png
 
Gold level support

Gold level support

Gold level support

Gold level support

Bronze level support

Bronze level support

Bronze level support

Bronze level support

What is LSS 2019?

 
 

THE LONDON SURGICAL SYMPOSIUM IS NOW IN ITS THIRTEENTH YEAR. THIS INCLUSIVE EDUCATIONAL FORUM BRINGS INTERNATIONAL EXPERTS ON SURGICAL INNOVATION TO LONDON TO DISCUSS ADVANCES IN A DIVERSE RANGE OF TOPICS IN GENERAL SURGERY. IT PROVIDES A FORUM FOR SURGICAL RESEARCHERS, TRAINEES AND CLINICIANS FROM ALL ASPECTS OF SURGICAL CARE TO PRESENT THEIR WORK AND TO ENJOY A DAY OF EDUCATION.  

 

SYMPOSIUM CHAIR / PROFESSOR GEORGE HANNA

SYMPOSIUM LEAD / MR AHMED AHMED


former LSS 2018 SPEAKERS

 

The Charles Pannett Lecture - Professor Brian Davidson

Hugh Dudley Lecture - Mr Terry Irwin

Chair's Invited Speaker - Mr Yuichi Mori

Simpson Smith Lecture - Mr Manoj Ramachandran


 

WATCH LSS 2018 RECORDINGS

lss 2019 TimetablE



lss 2019 speakers

 

Bigger and better than before, LSS 2019 will invite an exciting array of eminent speakers and world-class surgeons to share their wealth of knowledge and inspiring ideas. Following a tradition commenced at the inception of LSS, we will also host the highly esteemed, annual Hugh Dudley Lecture.


Chair’s Invited Speaker

“The importance of sham in surgical ICT”

2.jpg

Dr. Rasha Al Lamee

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and a clinical academic at Imperial College London. She has expertise in general and interventional cardiology. She is a clinical trialist and her research interests are in coronary intervention, invasive coronary physiology and invasive intravascular imaging.

Dr Al-Lamee is a world leading academic in cardiovascular research with a focus on clinical trials that impact the care of patients with coronary artery disease. She believes in the rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care.


Hugh Dudley Memorial Lecture

“Surgical clinical trials are just a waste of everybody's time”

karimbrohi-krlarge2[16882].jpg

Professor Karim Brohi

Karim Brohi is Professor of Trauma Sciences at Queen Mary University of London; Consultant Trauma & Vascular Surgeon at Barts Health NHS Trust and Director of the London Major Trauma System. He studied medicine at University College London and has trained in London, Cape Town and San Francisco. He runs active translational research programmes in the human response to injury and its effect on the coagulation and inflammation systems.


SIMPSON SMITH LECTURE

"NICE Reflections"

Prof+Haslam+head+%26+shoulders.jpg

Professor Sir David Anthony Haslam

David Haslam is Chair of the National Institute for Health and Care Excellence (NICE). He is also past-President and past Chairman of Council of the Royal College of General Practitioners, past-President of the British Medical Association, a former vice-chairman of the Academy of Medical Royal Colleges, and Professor of General Practice at the University of Nicosia, Cyprus. He was a GP in Ramsey, Cambridgeshire, for over 35 years and has been an expert member of the NHS National Quality Board, and National Clinical Adviser to both the Care Quality Commission and the Healthcare Commission. He is also a Director of the State Health Services Organisation in Cyprus.

He is a Fellow of the Royal College of GPs, a Fellow of the Faculty of Public Health, a Fellow of the Academy of Medical Educators, a Fellow of the Royal Society of Medicine, and a Fellow of the Royal College of Physicians.


Surgical trials - what do funding bodies expect?

2.jpg

Dr Andrew Cook

Andrew Cook is a Public Health Physician by training, and a pragmatic research methodologist by accident. Following training in public health medicine in the West Midlands, he began working for the predecessor of NIHR in 2006. Now is is a Consultant Advisor to NIHR’s Health Technology Assessment, Efficacy and Mechanism Evaluation, and Public Health Research programmes. He is also vice-chair of NICE’s Interventional Procedures Advisory Committee, and Associate Director of the Southampton Clinical Trials Unit.


Surgical trials - what are the top journals looking for?

fullsizeoutput_d7c+%28002%29.jpg

Dr Jessamy Bagenal

Jessamy gained her medical degree at University College London and intercalated in medical anthropology. She trained as a general and breast surgeon in the NHS, winning awards such as The Margaret Whitt award for clinical excellence from The Royal College of Surgeons of England and sitting on national committees. In 2014, Jessamy co-founded a medical education company that now partners with the Royal Society of Medicine to provide courses to healthcare professionals. In 2015 she won a National Medical Director’s fellowship with the Faculty of Medical Leadership and Management gaining exposure to governmental and arms-length healthcare organisations. Jessamy worked as a clinical editor for the British Medical Journal across their research and education teams and in 2017 was appointed Editor in Chief of BMJ Open Quality. Jessamy joined The Lancet in 2018. She continues to be a specialist advisor to the CQC and mentor for the Faculty of Medical Leadership and Management. Jessamy works across the peer review, comment and clinical commissioning teams.

 

LSS 2019

'The debate'

“Is big data the death of randomised controlled trials in surgery?”

 

FOR the motion

M+VBH.jpg

Professor Van Berge Henegouwen

Professor dr. Mark I. van Berge Henegouwen is chair of the upper GI unit at the Amsterdam University Medical Centers, chair of the Dutch Upper GI Cancer Audit and chair of the Dutch society of foregut surgeons of the Netherlands. He was appointed professor of Gastrointestinal Surgery in 2017 at the University of Amsterdam.

Mark van Berge Henegouwen is a Principal Investigator in upper GI cancer Surgery and main research activities are focused on improvement of outcomes in upper GI cancer surgery, outcomes and centralization in the Dutch Upper GI Cancer Audit, improvement of (minimally invasive) techniques, neoadjuvant treatment regimens in esophageal and gastric cancer and quality of life in upper GI cancer surgery.

AGAINST THE MOTION

1.jpg

Professor Jane Blazeby

Jane Blazeby is Professor of Surgery at the University of Bristol and an Honorary Consultant Surgeon at University Hospitals Bristol NHS Foundation Trust. She studied Medicine at the University of Bristol, undertook higher surgical training in the South West of England and she was an MRC Clinician Scientist between 2000 and 2006. Jane aims to establish evidence-based surgical practice in the UK. She is achieving this by leading and supporting research to evaluate surgical interventions and developing methods to optimise the process. She also is developing a new generation of surgeons who understand and can lead future studies in this area.

Jane directs the Bristol Centre of Surgical Research. This includes the Surgical Innovation theme of the Bristol Biomedical Research Centre and Royal College of England Surgical Trials Centre. She is Chief Investigator of a major RCT in bariatric surgery. She is supporting several other chief and principal investigators to design and deliver surgical trials. In 2015 she was appointed as an NIHR Senior Investigator. She has a long-standing interest in outcomes research and she is currently on the Core Outcome Measures in Effectiveness Trials (COMET) management group.


 NIHR Imperial Biomedical Research Centre (BRC)

Surgery & Surgical Technology Theme


The Surgery & Technology Theme is focused on improving the quality and safety of the surgical care pathway through technological innovation using our strong track record of convergent research in Design, Engineering, Medicine and Information Technology. Our three inter-related programmes of research, described below, aim to translate these innovations, in a safe and cost-effective manner, to produce outputs with significant health and economic impact that are transferable across all surgical specialities:

1) Surgical Robotics, Allied Technologies & Imaging

Development of innovative robotic platform technologies that incorporate hand-held and co-operatively-controlled instrumentation, surgical navigation and guidance, imaging and procedural automation.

 

2) Diagnostics & Sensing

Development of innovative technologies for peri-operative diagnostics and sensing, including biophotonics and spectroscopy tools for improving the diagnosis; and monitoring of conditions ranging from cancer to sepsis and malnutrition.

 

3) Translation & Service Delivery

Facilitate the sustainable translation and diffusion of innovation for the benefit of patients, health systems and the wider economy by leveraging digital technology and health informatics to improve the quality and safety of service delivery.


Zoltan+Takats.jpg

Professor Zoltan Takats

Professor Takats has obtained his PhD from Eötvös Loránd University, Budapest, Hungary. He has worked as a post-doctoral research associate at Purdue University, Indiana, USA. After returning to Hungary, he served as Director of Cell Screen Research Centre and also as Head of Newborn Screening and Metabolic Diagnostic Laboratory at Semmelweis University, Budapest.

Professor Takats was awarded the Starting Grant by the European Research Council in 2008 and he subsequently, became a Junior Research Group Leader at Justus Liebig University, Gießen, Germany. He moved to the United Kingdom in 2012 and currently works as a Professor of Analytical Chemistry at Imperial College London.

Professor Takats has pursued pioneering research in mass spectrometry and he is one of the founders of the field of ‘Ambient Mass Spectrometry’. He is the primary inventor of six mass spectrometric ionization techniques and author of 78 peer reviewed publications. He was the recipient of the prestigious Mattauch-Herzog Award of the German Mass Spectrometry Society and the Hungarian Star Award for Outstanding Innovators. He is the founder of Prosolia Inc, Medimass Ltd and Massprom Ltd, all companies pursuing analytical and medical device development.


Erik+Mayer.jpg

Mr Erik Mayer

Mr Mayer has both a private and an NHS practice at The Royal Marsden. He is a Clinical Senior Lecturer at Imperial College London, and an Honorary Consultant Surgeon at Imperial College Hospital NHS Trust and The Royal Marsden. His sub-specialist interests are in testicular, prostate and kidney cancer.

He is one of two surgeons in the South East England Supranetwork Testicular Multidisciplinary Team and performs retroperitoneal lymph node dissection for testis germ cell tumours. At The Royal Marsden, minimally invasive approaches to this surgery using both conventional keyhole surgery and robotic surgery are being developed to improve the outcomes, including shortening the hospital stay and recovery time.

He is also a robotic prostate surgeon and was part of the team that developed the first UK programme for robotic prostatectomy in 2004. He regularly performs robotic prostatectomy at The Royal Marsden and is developing a new pathway of care for patients who are eligible for salvage prostatectomy surgery for recurrent disease after other treatments.

Mr Mayer has completed a PhD thesis evaluating aspects of the Quality of Care in Surgery with emphasis on improved techniques for appraising surgical performance and outcomes. Continued research in this area is undertaken in the Centre for Health Policy (Institute for Global Health Innovation) and includes evaluating metrics that encompass the entire patient pathway and novel assessment tools for capturing the quality of the patient experience during treatment episodes. Health technology assessment research is focused on enhancing the quality and safety of minimally invasive surgery (including robotics) using image-guided technology.


Daniel+Leff.jpg

Mr Daniel Leff

Daniel is currently a Reader in Breast Surgery working in the Departments of BioSurgery and Surgical Technology and Hamlyn Centre for Robotic Surgery at Imperial College London. He is an Honorary Consultant in Oncoplastic Breast Surgery working within the Breast Unit at Imperial College Healthcare NHS Trust.

Daniel has undergone advanced Oncoplastic training having been competitively selected for a Training Interface Group (TIG) National Oncoplastic Fellowship, one of only nine such training posts in the United Kingdom. He trained at several centres of excellence in breast cancer and reconstructive breast surgery including the Imperial Breast Unit, the Royal Marsden NHS Foundation Trust and the St Andrews Centre for Plastic Surgery in Chelmsford. Daniel has a Master of Surgery degree in Oncoplastic Breast Surgery, he graduated with a first class distinction and attained the highest aggregate score of his peer group. In 2016, he won the "Issac Gukas Medal" for achievement in breast surgery.

Daniel received his PhD in Surgery from Imperial College London in 2009, working under the supervision of Professor Lord Ara Darzi and Professor Guang-Zhong Yang. Daniel's primary research interest is in the field of "surgical neuroergonomics" - optimising clinical performance through investigations of brain function in surgeons. He also pursues robotics, imaging and biosensing technology research geared to improving outcomes following breast conserving surgery and reconstructive breast surgery.

72nd SIMPSON SMITH TRAVEL AWARD

 

Simpson Smith.png

The Alex Simpson Smith Travelling Fellowship is an award offered to Senior Surgical Trainees (ST3 or above), or, to newly appointed Consultants (within 5 years of appointment) in any branch of surgery.

This is an opportunity for candidates to visit 'Centres of Excellence' abroad in order to obtain further experience or training within their speciality, currently not available in the UK. Preference will be given to applicants who can demonstrate that their visit will make a significant contribution to their surgical training. Financial support typically includes all travel and accommodation expenses.

On their return, successful applicants will be expected to submit a written report of their experience to the Simpson Smith Trustees and a brief presentation (~5mins) to the audience at the time of the next Simpson Smith lecture. The Fellowships are not intended for use to attend meetings or symposia.

Successful applicants will be notified at the Alex Simpson Memorial Lecture to be given at the London Surgical Symposium on MONDAY 16th OCTOBER 2019.

 

HOW TO APPLY?

 

Applicants wishing to apply should submit a brief outline of their proposed visit, stating the centre they wish to visit and explaining how this will enhance their training. An estimate of their proposed travelling costs and expenses should be attached together with a copy of their CV. Approval of their supervising consultants for this visit should also be shown.

WE WELCOME SUBMISSIONS VIA EMAIL TO: katy.hogben@nhs.net

SUBMISSION DEADLINE: SUNDAY 6th OCTOBER 2019.

 

Presenting.PNG

lss 2019 ABSTRACT COMPETITION

 

WE WELCOME SUBMISSION OF ABSTRACTS VIA EMAIL TO: abstract.ss3@imperial.ac.uk

SUBMISSION DEADLINE: SUNDAY 1st SEPTEMBER 2019

Please submit two abstracts, one anonymous and the other containing your full name and contact details. Abstracts should include the following headings

  • Introduction

  • Methods

  • Results

  • Conclusion

Please fully list each author and their institution, as for shortlisted abstracts, these details will be published on the conference programme.

Font should be Calibri, Size 12. Paragraphs should be single line spaced. Please include a word count (maximum 250 words).

Please title your email submission:

'Surgery Abstract - October 2019'

Please note that you submission will be processed for shortlisting and we will be in touch a couple of weeks after the deadline to let candidates know if they have been successful. 

SAF.jpg
 
INSTRUMENTS.jpg

The London Surgical Symposium is run by Imperial College London. It is a London based meeting open to all and it aims to deliver high quality, definitive lectures on important and controversial topics in surgery. It is inclusive, and we strongly encourage trainees, health professionals allied to surgery and clinical researchers in surgery to submit their work. We accept clinical audits as well as original research. 

 

A major purpose of this program is to create a social and professional network of surgeons and clinicians across London surgery and we welcome those from all hospitals both internationally and nationally.

We believe that the most important conversations often occur before or after the meeting and we encourage you to join the debate with us using #LSS2019

FIND US for LSS 2019

 

SYMPOSIUM VENUE

 

LSS 2019 is excited to announce it will be taking place at:

Ondaatje Theatre of the Royal Geographical Society (with The Institute of British Geographers)

1 Kensington Gore

London

SW7 2AR

Full directions to the Royal Geographical Society (with The Institute of British Geographers) can be found by clicking here

POST-CONFERENCE MEAL VENUE

TO BE ANNOUNCED

 
8704247341_3a8c921dd4_o.jpg

Contact Us

 
Name *
Name